Enterol® (Enterol®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspPowder for suspension for oral administration
Composition:

1 sachet contains:

Active ingredient: Saccharomyces boulardii lyophilizate 100 mg;

Auxiliary components: lactose monohydrate 13 mg, fructose 188.76 mg, silica / colloid dioxide 2.50 mg, tutti-frutti flavor 1.74 mg.

Description:Light brown powder with a fruity aroma.
Pharmacotherapeutic group:antidiarrhoeic remedy
Pharmacodynamics:

A drug Saccharomyces boulardii is a probiotic. According to the WHO definition, these are live microorganisms, applied in adequate amounts, have a healing effect on the human body.

Saccharomyces boulardii antimicrobial action due to antagonistic effect against pathogenic and opportunistic microorganisms: Clostridium difficile, Candida albicans, Candida kruesei, Candida pseudotropicalis, Klebsiella pneumoniae, Pseudomonas aeruginosa, Salmonella typhimurium, Yersinia enterocolitica, Escherichia coli, Shigella dysenteriae, Staphy­lococcus aureus and others, as well as Entamoeba histolitica and Lambliae.

Saccharomyces boulardii has an antitoxic effect against bacterial cytotoxic and enterotoxins, increases the enzymatic function of the intestine.

Cell wall component Saccharomyces boulardii Mannitol is a substrate for pathogenic strains Escherichia coli and Salmonella typhimurium, which causes their adhesion (attachment) to the surface Saccharomyces boulardii and the subsequent excretion from the body. Saccharomyces boulardii has a natural resistance to antibiotics.

Saccharomyces boulardii It is not an eubiotic; is not a part of the microflora of a healthy human body, respectively, after taking the drug Saccharomyces boulardii passes through the digestive tract unchanged without colonization and is completely eliminated from the body within 2-5 days after discontinuation of admission.

Indications:Treatment and prevention of diarrhea of ​​various etiologies in adults and children from 1 year, incl. with dysbacteriosis, irritable bowel syndrome, enterocolitis, antibiotic-associated diarrhea, travelers' diarrhea, diarrhea caused by Clostridium difficile.
Contraindications:

Hypersensitivity to any of the components of the drug.

The presence of a central venous catheter, since rare cases of fungemia in patients with a central venous catheter have been described after mechanical ingestion of the drug into the systemic bloodstream through a catheter as a result of the actions of medical personnel in hospital conditions.

Pregnancy and lactation:

The use of Enterol® during pregnancy or lactation is justified if the expected benefit exceeds the potential risk.

Dosing and Administration:

2-8 bags per day 1 hour before meals.

The contents of the sachet are mixed with water or other beverage.

Children from 1 year to 3 years - 1-3 packs twice a day.

Children from 3 years and adults - 2-4 packs twice a day.

For the treatment of acute diarrhea viral, bacterial or protozoal etiology the course of treatment is 5-10 days.

For the prevention of antibiotic-associated diarrhea the course of treatment on days corresponds to the course of antibiotic use.

To prevent recurrence of infection caused by Clostridium difficile, in combination with metronidazole or vancomycin, the course of treatment is 1 month.

For the prevention of travelers' diarrhea the course of treatment on days corresponds to the duration of the trip.

For the treatment of irritable bowel syndrome The drug should be continued until the symptoms disappear.

Reception of the drug for the treatment of acute diarrhea must necessarily be accompanied by rehydration (plentiful drink).

Side effects:

In rare cases, individual sensitivity to the components of the drug may occur.

Overdose:

Data on the drug overdose are not currently available.

Interaction:

Enterol® is not taken with antifungal drugs.

Compatible with antibiotics.

Special instructions:

Do not drink with hot and alcoholic beverages.

Do not heat mixed in a water or other beverage preparation in a microwave oven (microwave oven). Water or a drink, if necessary, is heated in a microwave oven, and then the preparation is added to warm water.

If, after two days of using Enterol® to treat acute diarrhea, there is no improvement, as well as an increase in temperature, the detection of blood or mucus in the stool, you should immediately contact your doctor.

The feeling of thirst and dry mouth indicates insufficient rehydration.

Features of the drug during the first admission or when it is canceled:

Not noted.

The actions of the doctor (paramedic) or the patient if one or several doses of the drug are missed:

Not required.

Special precautions for the destruction of unused medications:

Not required.

Effect on the ability to drive transp. cf. and fur:There was no adverse effect of the use of Enterol® on the ability to drive and complex mechanisms.
Form release / dosage:Powder for suspension for oral administration, 100 mg.
Packaging:

For 306 mg of powder in a paper-polyethylene-aluminum bag.

For 10, 14 or 20 bags together with instructions for use in a pack of cardboard.

For 10 sachets in a pack of cardboard without a top edge, and 2 or 5 of these packs in a pack of cardboard along with instructions for use.

Storage conditions:

At a temperature of 15 to 25 FROM.

Keep out of the reach of children.
Shelf life:

3 years.

Do not use after the date shown on the package.

Terms of leave from pharmacies:Without recipe
Registration number:LP-000622
Date of registration:21.09.2011
Date of cancellation:2016-09-21
The owner of the registration certificate:BIOCODEX BIOCODEX France
Manufacturer: & nbsp
BIOCODEX France
Representation: & nbspBIOCODEX BIOCODEX France
Information update date: & nbsp17.03.2016
Illustrated instructions
    Instructions
    Up